Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Clinical trial NCT05690035 · WITHDRAWN

Trial details

NCT number: NCT05690035
Sponsor: Sun Yat-sen University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer mCRC

Start date: 2025-07-01
Primary completion: 2025-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.